|
|
Volumn , Issue , 2013, Pages
|
|
"Right drug for the right patient": hurdles and the path forward in colorectal cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
TUMOR MARKER;
COLORECTAL NEOPLASMS;
GENETIC PREDISPOSITION;
GENETICS;
HUMAN;
METABOLISM;
MOLECULAR DIAGNOSIS;
MOLECULARLY TARGETED THERAPY;
MUTATION;
PATHOLOGY;
PATIENT SELECTION;
PERSONALIZED MEDICINE;
PHENOTYPE;
PREDICTIVE VALUE;
TREATMENT OUTCOME;
TRENDS;
ANTINEOPLASTIC AGENTS;
COLORECTAL NEOPLASMS;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
INDIVIDUALIZED MEDICINE;
MOLECULAR DIAGNOSTIC TECHNIQUES;
MOLECULAR TARGETED THERAPY;
MUTATION;
PATIENT SELECTION;
PHENOTYPE;
PREDICTIVE VALUE OF TESTS;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 84946212569
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.1200/EdBook_AM.2013.33.e115 Document Type: Review |
|
Times cited : (5)
|
|
References (0)
|